Cervical Cancer Care Continuum in South India: Evidence from a Community-based Screening Program
Tóm tắt
In India, cervical cancer screening is conducted at various levels; however, after screening, the adherence to the cancer care continuum is barely understood. This study evaluated a community-based cancer screening program conducted in a rural setting (Tirunelveli and Tuticorin districts) in South India and reviewed the completion of care continuum. In this longitudinal descriptive study involving secondary data collection, data from the case records of 2192 women who were consecutively screened between March 2015 and May 2016 were included. All women underwent conventional cytology-based screening (Pap smear) and Visual Inspection with Acetic Acid (VIA). Those for whom either test was positive were referred for histopathological confirmation. Patients with confirmed precancerous conditions and unsatisfactory Pap smears were referred for further management. In total, 2192 women were screened [age range, 17–69 years; mean (standard deviation), 39.2 (8.5)]. Common symptom and sign were white discharge per vaginum (34.9%) and cervical erosion (34.4%), respectively. The VIA was positive for 24% (523/2178; 14 women did not cooperate for VIA) and 113 (5.1%) had epithelial cell abnormality in the Pap smear test. Per histopathology findings, one woman had non-keratinizing squamous cell carcinoma. Seven, three, and four had cervical intraepithelial neoplasia I, II and III, respectively. Of 2192, 807 were eligible for referral (597 had positive results on either Pap or VIA). Among the 807 women referred, only 74 (9.2%) women visited the referral center. The follow-up rate was very poor accounting to fragmentation of care continuum. The success of the screening program depends on the completion of the care continuum.
Tài liệu tham khảo
Kaarthigeyan K. Cervical cancer in India and HPV vaccination. Indian J Med Paediatr Oncol 2012;33;7–12.
Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. Int J Womens Health 2015;7;405–14.
World Health Organization (WHO). Comprehensive cervical cancer control: a guide to essential practice. Geneva, Switzerland: World Health Organization; 2014.
Weinberg CR. HPV screening for cervical cancer in rural India. N Engl J Med 2009;361;305–6.
Banavali SD. Delivery of cancer care in rural India: experiences of establishing a rural comprehensive cancer care facility. Indian J Med Paediatr Oncol 2015;36;128–31.
Institute of Medicine. Cancer Control Opportunities in Low-and, Middle-Income countries. Washington, DC: The National Academies Press; 2007.
Bobdey S, Sathwara J, Jain A, Balasubramaniam G. Burden of cervical cancer and role of screening in India. Indian J Med Paediatr Oncol 2016;37;278–85.
Tamil Nadu Health Systems Project. Cervical Cancer Prevention Screening and Treatment. A Pilot Initiative of Tamil Nadu Health Systems Project. Tamil Nadu: Tamil Nadu Health Systems Project; 2014.
Thukral RK, Rahman S. Tamil Nadu District Factbook - Tirunelveli District (Key Socio-economic Data of Tirunelveli District, Tamil Nadu). 2nd ed. New Delhi: Datanet India Pvt Ltd.; 2018.
Government of Tamil Nadu-Department of Economics and Statistics. Statistical Hand Book. Tamil Nadu: Government of Tamil Nadu; 2017.
Udhavum Ullangal. Retrieved from http://udhavumullangal.org.in/ (accessed on January 17, 2019).
World Health Organization (WHO). WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: World Health Organization; 2013.
Nayar R, Wilbur DC. The Pap Test and Bethesda 2014. Acta Cytol 2015;59;121–32.
Pathak PK, Tripathi N, Subramanian SV. Secular trends in menarcheal age in India-evidence from the Indian human development survey. PLoS One 2014;9;e111027.
Henley SJ, Anderson RN, Thomas CC, Massetti GM, Peaker B, Richardson LC. Invasive cancer incidence, 2004–2013, and deaths, 2006–2015, in nonmetropolitan and metropolitan counties — United States. MMWR Surveill Summ 2017;66;1–13.
James CV, Moonesinghe R, Wilson-Frederick SM, Hall JE, Penman-Aguilar A, Bouye K. Racial/ethnic health disparities among rural adults — United States, 2012–2015. MMWR Surveill Summ 2017;66;1–9.
Shastri SS, Mittra I, Mishra GA, Gupta S, Dikshit R, Singh S, et al. Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J Natl Cancer Inst 2014;106;1–7.
Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 2007;370;398–406.
Srinivasan S, Johari V, Jesani A. Cervical Cancer Screening in India. In: Schroeder D, Cook J, Hirsch F, Fenet S, Muthuswamy V, editors. Ethics Dumping. Springer Briefs in Research and Innovation Governance; 2018, pp. 33–48.
Bal MS, Goyal R, Suri AK, Mohi MK. Detection of abnormal cervical cytology in Papanicolaou smears. J Cytol 2012;29;45–7.
Mwaka AD, Orach CG, Were EM, Lyratzopoulos G, Wabinga H, Roland M. Awareness of cervical cancer risk factors and symptoms: cross-sectional community survey in post-conflict northern Uganda. Health Expect 2016;19;854–67.
Simon AE, Waller J, Robb K, Wardle J. Patient delay in presentation of possible cancer symptoms: the contribution of knowledge and attitudes in a population sample from the United Kingdom. Cancer Epidemiol Biomarkers Prev 2010;19;2272–7.
Sheikh I, Ogden J. The role of knowledge and beliefs in help seeking behaviour for cancer: a quantitative and qualitative approach. Patient Educ Couns 1998;35;35–42.
Kulkarni PR, Rani H, Vimalambike MG, Ravishankar S. Opportunistic screening for cervical cancer in a tertiary hospital in Karnataka, India. Asian Pac J Cancer Prev 2013;14;5101–5.
Lawley TB, Lee RB, Kapela R. The significance of moderate and severe inflammation on class I Papanicolaou smear. Obstet Gynecol 1990;76;997–9.
Sankaranarayanan R, Thara S, Sharma A, Roy C, Shastri S, Mahé C, et al. Accuracy of conventional cytology: results from a multicentre screening study in India. J Med Screen 2004;11;77–84.
Idowu A, Olowookere SA, Fagbemi AT, Ogunlaja OA. Determinants of cervical cancer screening uptake among women in Ilorin, North Central Nigeria: a community-based study. J Cancer Epidemiol 2016;2016;6469240.
Isa Modibbo F, Dareng E, Bamisaye P, Jedy-Agba E, Adewole A, Oyeneyin L, et al. Qualitative study of barriers to cervical cancer screening among Nigerian women. BMJ Open 2016;6;e008533.
Austad K, Chary A, Xocop SM, Messmer S, King N, Carlson L, et al. Barriers to cervical cancer screening and the cervical cancer care continuum in rural guatemala: a mixed-method analysis. J Glob Oncol 2018;4;1–10.
Hodeib M, Chang J, Liu F, Ziogas A, Dilley S, Randall LM, et al. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer. Gynecol Oncol 2015; 138;121–7.
Forsythe LP, Alfano CM, Kent EE, Weaver KE, Bellizzi K, Arora N, et al. Social support, self-efficacy for decision-making, and follow-up care use in long-term cancer survivors. Psychooncology 2014;23;788–96.
Colligan L, Anderson JE, Potts HW, Berman J. Does the process map influence the outcome of quality improvement work? A comparison of a sequential flow diagram and a hierarchical task analysis diagram. BMC Health Serv Res 2010;10;7.
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388;1459–544.
Samb B, Van Bolhuis A, Alwan A, Etienne C. Delivery of universal primary care services for non-communicable diseases: The need for stronger country health systems. Commonwealth Health Ministers’ Update; 2011;68–71.